The pharmaceutical industry exports in Mexico have shown considerable fluctuations over the past decade. Starting at $1.95 billion in 2013, the value experienced modest declines and increases through 2023, ending at $1.85 billion in 2023. The year-on-year variation for 2023 was a growth of 3.06%, with a CAGR of 3.88% over the past five years. Notably, there were significant declines like the -18.3% in 2016, while 2021 saw a substantial increase of 20.57%. Despite the volatility, forecasted data shows an optimistic growth trajectory, reaching up to $2.12 billion by 2028, with a forecasted CAGR of 2.14% from 2023 to 2028.
Future trends to watch for:
- Potential impact of global economic conditions on export demand
- Advancements in pharmaceutical innovation leading to higher value exports
- Regulatory changes impacting trade agreements
- Investment in healthcare infrastructure driving growth
- Emerging markets as new export destinations
